Neogen Headquarters Expansion

Approved Brownfield Plan #81 (2022) to support Neogen’s headquarters expansion and eligible brownfield mechanisms addressing site-readiness and redevelopment costs.

Feasibility under a layered finance structure • eligibility and compliance requirements • stewardship of public participation relative to long-horizon economic value • accountability expectations tied to incentive use.

Enabled a $208 million investment delivering a 175,000 sq. ft. research and manufacturing facility, strengthening Lansing’s life sciences and advanced manufacturing capacity.